**Study Overview**: This research looks at the safety and effects of a medicine called Trastuzumab Deruxtecan, given as a shot under the skin, for people with serious cancer that has spread to other parts of their body. Trastuzumab Deruxtecan, or T-DXd, is a medicine that targets cancer cells with a specific marker called HER2.
**Eligibility**: To join, you must be at least 18 years old and have a specific type of cancer that has not responded to previous treatments. The cancer must have spread or be unable to be removed by surgery. You should have proof of cancer progression after the last treatment you received.
**Key Points to Consider**:
- **Length of Study and Visits**: The study involves multiple visits to the clinic for assessments and treatments.
- **Risks**: Prior heart issues or breathing problems may prevent participation due to potential side effects.
- **Compensation**: Participants may receive compensation for their time and travel.
This study is not suitable if you have had certain treatments before or have specific heart or lung conditions. Always consult with your doctor to ensure this study is right for you.
How understandable was the trial content above?
Hard to understand
Easy to understand